SAMSUNG BIOLOGICS CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 779,000 KRW | -1.39% |
|
-0.26% | +2.50% |
| May. 06 | Samsung Group Firms Set to Invest in US-based Latus Bio | MT |
| Apr. 25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 41.34B | ||||||
| 89.69B | ||||||
| 33.72B | ||||||
| 26.11B | ||||||
| 14.63B | ||||||
| 12.84B |
